These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1622442)

  • 1. Interaction of the new quinolone antibacterial agent levofloxacin with fenbufen in mice.
    Furuhama K; Akahane K; Tawara K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):406-8. PubMed ID: 1622442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phototoxic potential of the new quinolone antibacterial agent levofloxacin in mice.
    Wagai N; Yoshida M; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):404-5. PubMed ID: 1622441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute oral toxicity of the new quinolone antibacterial agent levofloxacin in mice, rats and monkeys.
    Kato M; Furuhama K; Yoshida M; Akahane K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):365-6. PubMed ID: 1622433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of nephrotoxic effects of the new quinolone antibacterial agent levofloxacin in rabbits.
    Inage F; Kato M; Yoshida M; Akahane K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):395-7. PubMed ID: 1622439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LD50 value, phototoxicity and convulsion induction test of the new quinolone antibacterial agent (S)-10-[(S)-(8-amino-6-azaspiro[3,4]octan-6-yl)]-9-fluoro-2, 3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxyl ic acid hemihydrate in laboratory animals.
    Shimoda K; Akahane K; Nomura M; Kato M
    Arzneimittelforschung; 1996 Jun; 46(6):625-8. PubMed ID: 8767355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-six-week oral toxicity of the new quinolone antibacterial agent levofloxacin in rats and cynomolgus monkeys.
    Kato M; Furuhama K; Woolley AP; Ashby R; Fowler JS; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):367-73. PubMed ID: 1622434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmotoxicity and ototoxicity of the new quinolone antibacterial agent levofloxacin in Long Evans rats.
    Nomura M; Yamada M; Yamamura H; Kajimura T; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):398-403. PubMed ID: 1622440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General pharmacology of the new quinolone antibacterial agent levofloxacin.
    Takasuna K; Kasai Y; Usui C; Takahashi M; Hirohashi M; Tamura K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):408-18. PubMed ID: 1622443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive toxicity of the new quinolone antibacterial agent levofloxacin in rats and rabbits.
    Watanabe T; Fujikawa K; Harada S; Ohura K; Sasaki T; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):374-7. PubMed ID: 1622435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenicity of the new quinolone antibacterial agent levofloxacin.
    Wagai N; Hattori H; Yamaguchi F; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):385-9. PubMed ID: 1622437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the new quinolone antibacterial agent levofloxacin on multiple organ carcinogenesis initiated with wide-spectrum carcinogens in rats.
    Kajimura T; Tojo H; Kudo G; Yamada M; Domon S; Nomura M; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):390-5. PubMed ID: 1622438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity of the new quinolone antibacterial agent levofloxacin.
    Shimada H; Itoh S; Hattori C; Tada S; Matsuura Y
    Arzneimittelforschung; 1992 Mar; 43(3A):378-85. PubMed ID: 1622436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of new quinolones on GABA(A) receptor-mediated response and its potentiation with felbinac in Xenopus oocytes injected with mouse-brain mRNA: correlation with convulsive potency in vivo.
    Kawakami J; Yamamoto K; Asanuma A; Yanagisawa K; Sawada Y; Iga T
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):246-54. PubMed ID: 9266796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
    Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
    Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological properties of a new fluoroquinolone on the central nervous system in rodents.
    Guiol C; Ledoussal C; Surgé JM
    Arzneimittelforschung; 1993 Jan; 43(1):56-60. PubMed ID: 8447850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-month oral toxicity study of the new quinolone antibacterial agent (S)-10-[(S)-(8-amino-6-azaspiro[3,4]octan-6-yl)-9-fluoro-2,3-dihydro-3- methyl-7-oxo-7H-pyrido [1,2,3-de] [1,4] benzoxazine-6-carboxylic acid hemihydrate in rats and cynomolgus monkeys.
    Sugawara T; Yoshida M; Shimoda K; Takada S; Miyamoto M; Nomura M; Kato M
    Arzneimittelforschung; 1996 Jul; 46(7):705-10. PubMed ID: 8842343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian variation in enoxacin-induced convulsions in mice coadministered with fenbufen.
    Masukawa T; Nakanishi K
    Jpn J Pharmacol; 1997 Feb; 73(2):175-7. PubMed ID: 9074952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
    Fukuda H; Kawamura Y
    Jpn J Antibiot; 2002 Jun; 55(3):270-80. PubMed ID: 12199111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampus and frontal cortex are the potential mediatory sites for convulsions induced by new quinolones and non-steroidal anti-inflammatory drugs.
    Motomura M; Kataoka Y; Takeo G; Shibayama K; Ohishi K; Nakamura T; Niwa M; Tsujihata M; Nagataki S
    Int J Clin Pharmacol Ther Toxicol; 1991 Jun; 29(6):223-7. PubMed ID: 1651287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Central stimulating effect of the combination of the new quinolone group of antimicrobials and nonsteroidal anti-inflammatory drugs in mice].
    Murayama S; Hara Y; Ally A; Suzuki T; Tamagawa M
    Nihon Yakurigaku Zasshi; 1992 Jan; 99(1):13-8. PubMed ID: 1313777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.